fda bpc-157 warning letter peptide BPC-157: Miracle Healing or Hidden Danger? FDA advisory committee votes to

1991 Nov;101(5):1399-408

List price is set by a pharmaceutical company, and in many cases is what uninsured diabetics pay Net price is the actual profit the company receives for a drug Rebates are discounts on drugs negotiated for insurance companies Co-payments are what an insured person pays for a prescription, out-of-pocket Deductibles , which can be as high as $10,000, are what insurance policies say must be paid before the insurer picks up the rest Insurance companies enlist third-party negotiators, called pharmacy benefit managers, to fix discounts with drug manufacturers that in turn result in smaller co-payment prices for their users

peptide is hygroscopic

Since fondaparinux sodium does not bind significantly to plasma proteins other than ATIII, no drug interactions by protein-binding displacement are expected